O3 Holding GmbH - Change in the Management Board   BEXBACH, GERMANY – 24th August 2026 – O3 Holding GmbH (the Company), the holding company of KD Pharma Group, announces today the appointment of Manja Boerman as Chief Executive Officer of KD Pharma Group, effective August 24, 2026.   Manja brings more than 20 years of international leadership e [ … ]

BIOGGIO, SWITZERLAND, 21 August 2026 - O3 Holding GmbH (the Company), the holding company of KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, announces that the Q2 2026 Interim Report, due  under the bond terms for The Company's FRN Senior Secured EUR 180,000,000 bond issue with ISIN NO0013360552 issued on 28 October 2024,  [ … ]

Disclosure of an inside Information under Article 17 of Regulation (EU) No 5G6/2014   O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan BEXBACH, GERMANY – 31 December 2025 – Today, O3 Holding GmbH (the Company), the holding company of KD Pharma Group, through its subsidiary K [ … ]